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A B S T R A C T
We investigated the skin sensitization hazard of glyphosate, the surfactant polyethylated tallow amine (POEA)
and two commercial glyphosate-containing formulations using different omics-technologies based on a human
dendritic cell (DC)-like cell line. First, the GARD™skin assay, investigating changes in the expression of 200
transcripts upon cell exposure to xenobiotics, was used for skin sensitization prediction. POEA and the for-
mulations were classified as skin sensitizers while glyphosate alone was classified as a non-sensitizer.
Interestingly, the mixture of POEA together with glyphosate displayed a similar sensitizing prediction as POEA
alone, indicating that glyphosate likely does not increase the sensitizing capacity when associated with POEA.
Moreover, mass spectrometry analysis identified differentially regulated protein groups and predicted molecular
pathways based on a proteomic approach in response to cell exposures with glyphosate, POEA and the gly-
phosate-containing formulations. Based on the protein expression data, predicted pathways were linked to
immunologically relevant events and regulated proteins further to cholesterol biosynthesis and homeostasis as
well as to autophagy, identifying novel aspects of DC responses after exposure to xenobiotics. In summary, we
here present an integrative analysis involving advanced technologies to elucidate the molecular mechanisms
behind DC activation in the skin sensitization process triggered by the investigated agrochemical materials.
Significance: The use of glyphosate has increased worldwide, and much effort has been made to improve risk
assessments and to further elucidate the mechanisms behind any potential human health hazard of this chemical
and its agrochemical formulations. In this context, omics-based techniques can provide a multiparametric ap-
proach, including several biomarkers, to expand the mechanistic knowledge of xenobiotics-induced toxicity.
Based on this, we performed the integration of GARD™skin and proteomic data to elucidate the skin sensitization
hazard of POEA, glyphosate and its two commercial mixtures, and to investigate cellular responses more in detail
on protein level. The proteomic data indicate the regulation of immune response-related pathways and proteins
associated with cholesterol biosynthesis and homeostasis as well as to autophagy, identifying novel aspects of DC
responses after exposure to xenobiotics. Therefore, our data show the applicability of a multiparametric in-
tegrated approach for the mechanism-based hazard evaluation of xenobiotics, eventually complementing deci-
sion making in the holistic risk assessment of chemicals regarding their allergenic potential in humans.
1. Introduction
Herbicides based on glyphosate [N-(phosphonomethyl) glycine]
have been used for weed control in agricultural production and home
gardens since the 1970s and the first formulation launched on the
market was Roundup® [1,2]. Today, more than 750 different products
containing glyphosate as the main active ingredient have been catalo-
gued [1]. Glyphosate exhibits its herbicidal activity by inhibiting the 5-
enolpyruvylshikimate-3-phosphate synthase [3]. Since this enzyme is
not present in humans, the impact of glyphosate on human health has
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been assumed to be minimal [4]. However, glyphosate and its for-
mulations are currently under examination regarding their human
toxicity [5], and their widespread and increasing use [6] warrants more
scientific data to explain their effects on human immune cells.
Although several reports have investigated the potential toxicity of
glyphosate and its commercial formulations, there is no consensus re-
garding their immunotoxic effects and other human health hazards. The
European Food Safety Authority (EFSA) has reported that glyphosate is
“unlikely to pose a hazard for humans” [7], while the International
Agency for Research on Cancer (IARC) of the World Health Organiza-
tion (WHO) has classified the chemical as “probably carcinogenic to
humans” [1]. As herbicidal formulations are mixtures of several che-
micals, it has been suggested that the other ingredients, which are
commonly kept confidential and are misleadingly called “inert” by the
manufactures, can give rise to toxicity apart from the active ingredient
glyphosate [8]. A review of epidemiological studies of the relation
between glyphosate and cancer indicates that it would be important to
examine also the multi-component herbicide formulations [9], since
they can show a different toxicity profile from the active ingredient
alone and may therefore be classified differently by regulatory autho-
rities [10]. Also, the finished product represents the “real-life” mixtures
to which humans (e.g. workers and consumers) are exposed to.
Furthermore, combined effects (e.g. synergy, addition or potentia-
tion) of the different components in a mixture, such as an herbicidal
formulation, could influence the immunological response [11,12]. One
group of commonly used co-formulants in herbicide formulations are
surfactants, which improve the foliar uptake of the active ingredient
[2,13]. Among them, polyethylated tallow amine (POEA) has been
widely used and consists of a mixture of compounds containing dif-
ferent alkyl group substituents obtained from animal-derived fatty acids
[13]. Findings have indicated the potential toxicity of this “inert” in-
gredient in glyphosate-based formulations [14]. Among the human
health risks highlighted are, for example, carcinogenicity [1] and en-
docrine disruption, though the latter may rather be related to other co-
formulants and/or a cocktail effect in the commercial formulations
[15]. In addition, the toxicological assessments conducted by the EFSA
has identified scientific evidence supporting a higher toxicity of POEA
in several toxicological endpoints, including skin irritation and sensi-
tization, when compared to the glyphosate alone [16]. In view of this,
POEA has been prohibited in the European Union [17] and thus some
manufacturers have replaced it with other surfactants, such as alkyl
polyglycoside [2]. However, there is no evidence in humans if non-
POEA surfactants provide safer formulations in comparison to the
POEA-containing ones. Notably, in this context, knowledge about the
cellular and molecular mechanisms underlying skin immunotoxicity
induced by glyphosate and its commercial mixtures remains lacking.
While the exposure to glyphosate is mainly discussed in the context
of the main users, i.e. farmers, traces of glyphosate are found in the
urine of the general population not connected to agricultural occupa-
tions [18,19]. This further highlights the importance of performing risk
assessment and making scientifically sound decisions on the restrictions
or occupational care management of glyphosate-containing formula-
tions. Historically, decisions for assessing the potential for xenobiotics
to cause allergic contact dermatitis are derived from experiments on
animals, e.g. the murine local lymph node assay (LLNA) [20]. However,
scientific progress in the development of innovative in vitro predictive
methods and several other factors, including economical, ethical and
political concerns, have made animal testing increasingly unfavourable
[21,22]. Associated with this, legislations, such as the Registration,
Evaluation, Authorization and Restriction of Chemicals (REACH), state
that animal testing for regulatory purposes should only be conducted as
a last resort [23,24]. Moreover, the European Union has banned the use
of animal testing in hazard and risk assessment of cosmetic materials as
well as the sale of products undergone in vivo tests since 2009 and 2013,
respectively [25].
As a consequence, the development of in vitro methods to identify
allergenic materials has been encouraged, as recently reviewed [26]. In
fact, the mechanistic understanding of the chemical-induced skin sen-
sitization process in humans, summarized in the adverse outcome
pathway (AOP) for skin sensitization published by the Organisation for
Economic Co-operation and Development (OECD) in 2012 [27], has
driven such progress. Modern technology, such as omics-based techni-
ques, can enhance the mechanistic knowledge of chemical toxicity
through a multiparametric analysis of several biomarkers [28], which
in turn can provide better prediction of chemical-induced adverse ef-
fects on human health. Thus, this mechanism-based approach con-
tributes to the establishment of a holistic human health risk assessment
of xenobiotics [29]. Among the in vitro techniques developed until now
for skin sensitization prediction, several are based on human dendritic
cell (DC) models [26], since DCs has a central role in the skin sensiti-
zation pathway [27]. In this regard, their gene and protein regulation
pathways can reveal much about the underlying mechanisms and mo-
lecular events triggering allergic reactions towards chemicals and
complex mixtures, such as glyphosate-based formulations.
In this study, we investigated the skin sensitization capacity of
glyphosate, the surfactant POEA and two commercially available POEA-
free glyphosate-based formulations using different omics-technologies
and a human DC model. First, a transcriptomic-based analysis with the
Genomic Allergen Rapid Detection (GARD™) assay for chemical skin
sensitization prediction (GARD™skin) was performed. Thereafter, a
proteomic-based approach was carried out by mass spectrometry (MS)
analysis of purified protein extracts from chemical-exposed cells.
Presented here are the protein groups differentially regulated in re-
sponse to the glyphosate formulations and the surfactant POEA.
Pathways associated with differentially regulated protein groups
showed immunologically relevant events, which can lead to a better
understanding of the molecular mechanisms induced by such materials.
Furthermore, we present data from in vitro experiments indicating that
glyphosate, in contrast to the surfactant POEA and the two commer-
cially finished products tested, has no immunotoxic potential in the
context of human skin sensitization.
2. Materials and methods
2.1. Chemicals and reagents
POEA was purchased from Crescent Chemical Company (Islandia,
NY, USA). The following commercial formulations were obtained from
a Swedish agricultural supplies retailer and received as gifts from the
Swedish University of Agricultural Sciences (Alnarp, Sweden):
Roundup® Flex (containing the surfactant alkyl polyglycoside and
588 g/L glyphosate; registration number of the Swedish Chemicals
Agency: 5065) and Jablo (containing the surfactant ether amine
ethoxylate and 441 g/L glyphosate; registration number of the Swedish
Chemicals Agency: 4972). Dimethyl sulfoxide (DMSO), p-phenylene-
diamine (PPD), HyClone™ minimum essential medium alpha mod-
ification with L-glutamine, ribo- and deoxyribonucleosides (MEM-α)
and TRizol® were purchased from Thermo Fisher Scientific (Waltham,
MA, USA). Recombinant human granulocyte-macrophage colony-sti-
mulating factor (rhGM-CSF) was purchased from PeproTech (Rocky
Hill, NJ, USA). Propidium iodide (PI), FITC-conjugated anti-human
[CD86 (FUN-1), HLA-DR (L243), CD34 (581) and isotype control anti-
IgG1 (MOPC-21)] and PE-conjugated anti-human [CD54 (HA58), CD80
(L307) and isotype control anti-IgG1 (MOPC-21)] antibodies were ac-
quired from BD Biosciences (San Jose, CA, USA). FITC-conjugated anti-
human CD1a (NA1/34) and PE-conjugated anti-human CD14 (TÜK4)
antibodies were purchased from Dako (Santa Clara, CA, USA). Direct-
zol™ RNA MiniPrep column purification kit and trypsin were acquired
from Zymo Research (Irvine, CA, USA) and Promega Biotech AB
(Madison, WI, USA), respectively. Hybridization buffer, reporter co-
deset, capture probeset and nCounter® cartridges were purchased from
NanoString® Technologies (Seattle, WA, USA). Protease inhibitor tables
T. Lindberg, et al. Journal of Proteomics 217 (2020) 103647
2
EDTA-free and Silica C18 UltraMicro spin columns were acquired from
Roche Diagnostics GmbH (Mannheim, Germany) and The Nest group
(Southborough, MA, USA), respectively. All other chemicals were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Cell culture
MUTZ-3-derived cells (DSMZ, Braunschweig, Germany) were cul-
tured in MEM-α supplemented with 20% (v/v) fetal bovine serum (FBS)
and rhGM-CSF (40 ng/mL), and maintained in a humidified atmosphere
of 5% CO2 in air at 37 °C. Cell viability was analyzed using LUNA™
automated cell counter (Logos Biosystems, Annandale, VA, USA), ac-
cording to manufacturer's instructions. A cell viability value> 90% was
considered satisfactory to carry out the experiments, which were per-
formed using three independent batches of cells. Moreover, quality
control analysis was performed for each cell batch using BD FACSCanto
II flow cytometer (Biosciences, San Jose, CA, USA), in accordance with
previously published protocols [30,31]. For that, the following anti-
bodies were used: FITC-conjugated anti-human CD1a, CD34, CD86 or
HLA-DR, and PE-conjugated anti-human CD14, CD54 or CD80; FITC- or
PE-anti-IgG1 were used as isotype controls, while staining with PI
(1 μg/mL) was performed for cell viability analysis.
2.3. Cell exposure with the test materials
Cell exposures and selection of input non-cytotoxic concentration of
each test material (e.g. test material concentration inducing 90% re-
lative viability, when compared to unexposed cells, namely RV90 value)
were performed according to established protocols [31,32]. In short,
test materials were diluted in appropriate vehicles (Table 1) and the
cells (2× 105 cells/mL) were exposed to different concentrations for
24 h. After that, flow cytometer analysis was conducted to evaluate the
cell viability using PI staining and then to obtain the RV90 values. In the
case of non-cytotoxic materials, an input concentration of 500 μM was
used. After that, cells were exposed to each test material at input con-
centration (Table 1) to carry out the flow cytometric analysis of CD86
expression and transcriptional analysis. Cell exposures were performed
in triplicate cell batch reactions, i.e. a new cell batch was used each
exposure round, resulting in a total of 18 samples. In addition, three
replicate cell batches were exposed to POEA combined with glyphosate
in their respective input concentrations as listed in Table 1 in order to
investigate effects of this mixture. Total RNA was collected by lysing
2× 105 cells/exposure in TRIzol® and stored at −20 °C until RNA
purification and further processing for transcriptional analysis and
GARD™ skin predictions. Schematic view of experimental procedures
can be seen in Fig. 1.
2.4. GARD™skin assay
The in vitro assay GARD™skin (SenzaGen AB, Lund, Sweden) was
used to predict the ability of chemical substances to induce skin sen-
sitization. This technology was developed based on a transcriptomic
approach and machine learning techniques, comprising a predictive
biomarker signature of 200 transcripts associated with the skin sensi-
tization capacity of chemicals [30]. Also, GARD™skin has been de-
monstrated suitable for skin sensitization prediction of a wide variety of
chemical classes and complex mixtures [12,31,33–36]. Total RNA was
isolated from the cells lysed in TRIzol® reagent using the Direct-zol™
RNA MiniPrep column purification kit (Zymo Research), according to
manufacturer’ instructions. For each sample, concentration and RNA
integrity was determined with an Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, USA). The following gene expression ana-
lysis was performed on NanoString® GEN2 nCounter analysis system
(NanoString® Technologies) using the GARD™skin assay. In brief, 5 μL
RNA sample were mixed with 8 μL master mix, comprising hybridiza-
tion buffer and reporter CodeSet, and 2 μL Capture ProbeSet followed
by 24 h hybridization at 65 °C using a 3Prime thermal cycler (Bibby
Scientific, Staffordshire, UK). Samples were then processed and trans-
ferred to a 12-well nCounter® cartridge in the GEN2 Prep station 5 s set
at high sensitivity followed by data collection on the Digital Analyzer
5 s with an imaging resolution of 555 fields of view. The Reporter Code
Count files (RCC) files were then downloaded from the Digital Analyzer
and processed using SenzaGen software version 1.0 (SenzaGen AB),
which conducts both NanoString® quality control and data normal-
ization. A support vector machine (SVM) algorithm was used to assign a
so-called decision value (DV) to each test material replicate. A test
material is classified as skin sensitizer when the SVM median output
value is> 0 of the three independent replicates, while a median
DV < 0 classifies the material as a non-sensitizer.
2.5. Proteomic analysis
2.5.1. Protein extraction and concentration determination
For proteomic analysis, cells were also exposed to each test material
at input concentration (Table 1). After 24 h, cells were harvested and
processed for MS analysis by pelleting the chemically exposed cells in a
Table 1
Test materials used for cell exposures.
Material Abbreviation CAS no. Vehicle Classification Input concentration
Double-distilled water H2O na na Unexposed 0.1% (v/v)
Dimethyl sulfoxide DMSO 67‐68-5 na Vehicle control 0.1% (v/v)
p-Phenylenediamine PPD 106‐50-3 DMSO Positive control 75 μM
Glyphosate GLY 1071-83-6 H2O na 500 μM
Polyethylated tallow amine POEA 61791‐26-2 H2O na 0.001% (v/v)
Roundup® Flex na na H2O na 0.12% (v/v)
Jablo na na H2O na 0.008% (v/v)
na: not applicable.
Fig. 1. Schematic view of experimental procedures.
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maximum recovery Eppendorf tube followed by washing with phos-
phate buffered saline (PBS) before flash freezing of the pellet in liquid
nitrogen. Cell pellets were stored at −80 °C before further MS proces-
sing. Each cell batch of chemical exposure was performed in duplicates
of 2×106 cells/exposure, and thereafter pooled to ensure a sufficient
protein amount for MS analysis. In addition, triplicates of unexposed
(water) samples were run resulting in a total of 21 samples for MS
analysis. Following cellular exposure proteins were extracted from each
sample by lysing the cells in 150 μL lysis buffer (8M urea, 39mM Tris,
5 mM MgAc, 4% CHAPS, protease inhibitor tablet) through three
freeze/thaw cycles and separating supernatant and cell debris by cen-
trifugation at 16000×g for 30min. Protein extracts were stored in
−80 °C until further processing. Protein concentration determination
was performed using the Total Protein Micro-Lowry kit (Sigma-Aldrich)
according to manufacturer's instructions. The concentration was de-
termined by measuring the absorbance at 650 nm and 50 μg per sample
were used for further processing.
2.5.2. In gel trypsin digestion and mass spectrometry
Proteins were separated on an SDS-PAGE gel and digested into
peptides using trypsin. Trypsinated peptides were then de-salted using
UltraMicro spin columns (Silica C18, SUM SS18 V, Nest group) as de-
scribed in Chawade et al. [37]. Peptides were thereafter resuspended in
0.1% formic acid (FA) and loaded into an EASY-nano liquid chromato-
graphy (LC) system 1200 (Thermo Fisher Scientific). Peptides were in-
jected directly into the analytical column, a 15 cm long fused silica
capillary (75 μm×16 cm Pico Tip Emitter, New Objective, Woburn,
MA, USA) packed in-house with C18 material ReproSil-Pur 1.9 μm (Dr
Maisch GmbH, Germany). Peptides were separated using an 80min
gradient from 5% to 90% solvent B (80% acetonitrile, 0.1% FA, v/v) at
a constant flow rate of 250 nL/min. The nLC system was coupled with a
Q-Exactive™ HF-X (Hybrid Quadrupole-Orbitrap™) (Thermo Fisher
Scientific) operated in a positive mode for data-dependent acquisition
(DDA). The Orbitrap acquired the full MS scan with an automatic gain
control (AGC) target value of 3× 106 ions and a maximum fill time of
50ms. The 20 most abundant peptide ions were selected from the MS
for higher energy collision-induced dissociation (HCD) fragmentation
(collision energy: 40 V). The instrument was scanning at a target MS1
resolution of 120,000 between 375 and 1500m/z window with 15,000
MS/MS resolution for a target of 1×105 and a maximum injection time
of 20ms using an isolation window of 1.2m/z.
2.5.3. Downstream processing of peptide data
Raw data from Xcalibur software (Thermo Fisher Scientific) were
converted to mzML format using ProteoWizard [38] and MGF peak list
files were subsequently generated based on the DeMix cloning method
[39] before further processing in the Proteios Software Environment
(http://www.proteios.org) [40]. Peptide identification was performed
using MS-GF+ [41] with a precursor tolerance of 10 ppm, fixed car-
bamidomethylation and variable methionine oxidation and protein n-
terminal acetylation, with instrument set to QExactive against the
THISP database level 2, version 2018-06-01 [42], containing 317,620
protein entries including decoys. Subsequent data processing for label
free quantification (LFQ) was performed in Proteios using Dinosaur
[43] feature detection with matching and alignment between runs as
described by Sandin et al. [44]. Features were matched to MSMS
identifications filtered at a peptide spectrum match false discovery rate
(FDR) of 0.002 but maintaining MSMS identifications passing an FDR
threshold of 0.1 when the same peptide sequence was passing the 0.002
FDR threshold elsewhere in the dataset. Peptide abundances extracted
from MS1 intensities using the LFQ workflow were normalized using a
retention-time-segmented LOESS approach in NormalyzerDE [45]. In
total, 65,717 peptide feature rows were rolled up to 6029 protein
groups using an in-house pyhton implementation (LK Möller, MSc
Thesis) of reference peptide-based scaling [46]. The protein group table
contained 15 decoy entries after the protein grouping, indicating a
protein level FDR<0.003. The raw and processed MS data have been
deposited to the ProteomeXchange Consortium via the PRIDE [47]
partner repository with the dataset identifier PXD016859 and https://
doi.org/10.6019/PXD016859.
For subsequent analysis, one sample of Jablo had to be removed due
to a mix-up with another sample leaving a total of 20 samples for fur-
ther analysis. Missing values in the dataset were put to 19.24, which
were the lowest value in the data matrix and all values were log2
transformed. Visualization of the data was performed in Qlucore Omics
Explorer 3.5 (Qlucore AB, Lund, Sweden). Subsequent principal com-
ponent analysis (PCA) visualization of the data revealed batch effects,
which were corrected with ComBat [48] provided by the sva package
[49] in RStudio [50], before further analysis.
2.6. Statistical analysis
Data are expressed as mean or mean ± SD of three independent
assays. The inter group variation on CD86 expression assessment was
measured by Student's t-test at p < .05 established as statistical sig-
nificance. For proteomic analysis, each group of proteins was associated
with a corresponding set of gene(s) to identify predicted pathways
enriched by differently regulated protein groups. Two-group compar-
isons (one-way ANOVA) were made between individual materials and
DMSO and unexposed controls at a significance level of 0.05 (FDR) and
an absolute fold change cut-off of 1.3. Subsequent fold changes and p-
values were used as input for the Key Pathway Advisor (KPA) tool
(version 17.4) [51], which associates the input genes with upstream
and downstream processes to allow biological interpretation. Default
settings were used and Key Hubs Calculation Algorithm was set to
“Casual Reasoning Analysis”. Differentially regulated protein groups
were visualized in volcano plots using RStudio.
3. Results
3.1. Glyphosate-containing formulations and POEA are predicted as
sensitizing by the GARD™skin assay
Following 24 h of exposure with different concentrations of gly-
phosate-containing formulations (Roundup® Flex and Jablo) as well as
the surfactant POEA and pure glyphosate, cytotoxicity analysis was
performed using PI staining to define the input concentration for each
test material (Table 1). Cells were then exposed to the test materials at
input concentrations for 24 h and the maturity state of the cells was
assessed by measuring levels of cell surface expression of the co-sti-
mulatory marker CD86 (Fig. 2). Only the positive control PPD induced a
significant upregulation of CD86 expression (p < .05) in comparison to
unexposed control, while Roundup® Flex, Jablo and POEA did not in-
duce any upregulation. Cell exposure with pure glyphosate resulted in a
modest downregulation compared to control (p < .05). No significant
difference between DMSO and unexposed controls was observed.
Furthermore, skin sensitization hazard predictions were performed
with the GARD™skin assay. Transcriptomic analysis of the 200 bio-
markers from the GARD™skin prediction signature was carried out
using the NanoString® nCounter™ System. The skin sensitizing hazard
was predicted using an SVM algorithm where each test material re-
plicate was given a DV (Fig. 3). As expected, PPD and DMSO were
correctly classified as skin sensitizer and non-sensitizer, respectively.
Also, glyphosate was classified as a non-sensitizer with a mean SVM DV
of−1.45. Although, POEA showed a mean DV of 4.56, which classified
it as skin sensitizer. Interestingly, the mixture of POEA and glyphosate
displayed a similar profile (mean DV=4.96), indicating that these
materials have no combined effect as judged by the GARD™ DV.
Moreover, both glyphosate-containing formulations, Roundup® Flex
(mean DV=8.80) and Jablo (mean DV=9.70), were classified as skin
sensitizers.
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3.2. Profiling of agrochemical-induced changes in the cellular proteome
Initially, peptide data, generated from the trypsin-digested cells
exposed with test materials for 24 h were normalized and assembled to
protein groups. In total, this resulted in 6029 protein groups. PCA
evaluation was used to identify patterns, i.e. which samples exhibit a
similar protein expression profile. As a first step, unsupervised clus-
tering of all protein groups was performed (Fig. 4A). A clear separation
between sensitizers (PPD, POEA, Roundup® Flex and Jablo) and non-
sensitizers (unexposed, DMSO, glyphosate) is observed. Separating the
sensitizers from the non-sensitizers based on a one-way ANOVA
(FDR=0.05) resulted in 1726 differentially expressed protein groups
(data not shown). Additionally, by applying a multi-group comparison
(FDR=0.05) based on all the treatments, i.e. clustering of the in-
dividual treatments most alike based on their protein expression, a si-
milar pattern was observed as when unsupervised clustering was ap-
plied (Fig. 4B). Interestingly, samples representing exposures with
POEA and Jablo clustered together.
3.3. Differentially regulated protein groups are linked to genes associated
with immune-related pathways
Protein groups, assembled from the peptide data, were investigated
by KPA to identify enriched predicted pathways induced by exposure
with the glyphosate-based formulations. The input data for the KPA
analysis were gene names associated to the differentially regulated
protein groups identified by comparing each formulation to the control
group at a specific cut-off level. At a significance level of 0.05 (FDR)
and a fold change cut-off of 1.3, the number of unique protein groups
that were identified as differentially expressed, as compared to controls
DMSO and unexposed, were 365 for Roundup® Flex exposure (Fig. 5A),
140 for Jablo exposure (Fig. 5B) and 124 for POEA exposure (Fig. 5C).
A total of 80 protein groups were commonly regulated by Jablo and
Roundup® Flex (Fig. 5D). With the same comparison and at the same
fold change cut-off and significance level, glyphosate exposure of cells
resulted in only 3 regulated protein groups (data not shown).
Fig. 2. Analysis of CD86 expression induced by the test materials. Cells were exposed to the test materials at non-cytotoxic input concentrations for 24 h. After that,
CD86 expression was determined by flow cytometry. The values were normalized to vehicle control. Error bars indicate the mean standard deviation in percentage
out of three biological replicates for each exposure. (⁎p < .05 vs. control).
Fig. 3. Transcriptomic-based evaluation using GARD™skin assay. Cells were
exposed to the test materials at non-cytotoxic input concentrations for 24 h.
Total RNA samples were then obtained to perform transcriptomic-based eva-
luation. Transcript analysis of the 200 genomic biomarkers from the
GARD™skin prediction signature was carried using a NanoString® GEN2
nCounter analysis system. A test material was classified as a skin sensitizer
when the support vector machine median output value of the three independent
replicates> 0.
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Among the 47 proteins commonly regulated by Roundup® Flex,
Jablo, and POEA (Supplementary Table S1), three enzymes appear that
are all also part of the GARD™skin prediction signature, namely 7-de-
hydrocholesterol reductase (DHCR7), 24-dehydrocholesterol reductase
(DHCR24) and lanosterol-14a-demethylase, the product of CYP51A1
[52]. Other proteins differentially expressed in response to POEA and
the two formulations with highest fold changes are more enzymes and
proteins involved in cholesterol synthesis and homeostasis, such as
farnesyl-diphosphate farnesyltransferase 1 (FDFT1) and apolipoprotein
B (APOB) [52]. Further, thymidylate synthase (TYMS) [53], involved in
DNA repair, and p62/SQSTM1, a multifunctional ubiquitin-binding
protein [54], are also among the differentially regulated proteins.
Furthermore, KPA associates the genes connected to the protein
groups with pathways and key hubs, a molecule that is predicted to be
upstream of the input transcripts in the KPA analysis, to allow for
biological interpretation of the data. The KPA analysis revealed several
predicted pathways enriched in the exposures by the different glypho-
sate formulations (Fig. 6). A cut-off of -log(p-value)≥ 3.88, corre-
sponding to a p-value of ≤0.000132, was chosen to include all path-
ways predicted in response to exposure with POEA and accordingly all
pathways (13 and 25 pathways for Roundup® Flex and Jablo, respec-
tively), at the same cut-off. The total number of enriched pathways was
25 for Roundup® Flex, 51 for Jablo and 5 for POEA. Furthermore, three
pathways were predicted to be enriched in cell exposures with all three
substances, namely, “Sirtuin6 regulation and functions”, “Role of ER
stress in obesity and type 2 diabetes” and “mTORC1 downstream sig-
naling”.
4. Discussion
Recently, much effort has been invested in elucidating the toxicity
of glyphosate and its commercial “real-life” agrochemical formulations.
Controversies related to what actually induces toxic reactions from a
formulation have led to different regulations being implemented
around the world and no consensus has been reached [5]. As glypho-
sate-containing formulations are among the most used herbicides
worldwide [6], it is essential to increase our knowledge about their
impact on human health. In the case of skin sensitization assessment,
there is no global harmonization of needed data, and testing require-
ments among the regulatory agencies from different regions vary.
However, human-relevant in vitro approaches have recently started to
receive regulatory acceptance [55]. Decision making regarding the
toxicity testing of pesticides is mainly performed on pure substances by
some authorities (e.g. EFSA), i.e. ingredients to be used in various
products are tested one by one. However, we are exposed to the final
product, which represents a complex mixture of different chemicals. As
there are examples where formulation ingredients were assessed as safe
yet allergic reaction occurred to the product, also complete formula-
tions should be thoroughly investigated regarding their human health
hazard [56]. For instance, specific mixtures of “inactive” ingredients,
namely excipients, used in drug products to provide the desired phy-
sical properties have been associated with allergy cases in humans even
though the active pharmaceutical ingredient does not show allergenic
potential [57]. Similarly, the combination of chemicals, as found in an
herbicidal mixture, can show a different toxicological profile compared
to the one of the main active ingredient alone. In view of this, some
authorities, such as the US regulatory agency [58], make the testing of
both pure substance and final product mandatory for skin sensitization
hazard assessment. In fact, some reports have shown that glyphosate
tested alone had a reduced toxicity as compared to the commercial
glyphosate-based formulations [13].
Most of the knowledge regarding the toxicological effects of xeno-
biotics has traditionally been generated by animal experimentation,
which has been criticized. One reason is that these experiments suffer
from poor human toxicological utility, especially for predicting im-
munological effects [59]. In view of this, human-relevant in vitro
methods have been developed to carry out the hazard identification for
contact allergens. In fact, some of these in vitro methods for skin sen-
sitization prediction have shown better performance than animal assays
[26]. The objective of this study was to perform in vitro sensitization
testing using agrochemicals with a parallel MS-based proteomic ap-
proach to investigate the underlying cellular mechanisms induced by
agrochemicals and their formulations. The experimental setup of the in
vitro assay GARD™skin was used to stimulate cells of a human DC-like
Fig. 4. PCA plots of protein groups. PCA plots based on the expression profile of the 6029 protein groups of the unexposed cells (green) and those one exposed to
DMSO (red), PPD (white), POEA (pink), Glyphosate (blue), Roundup® Flex (yellow) or Jablo (orange) for 24 h. (A) Unsupervised clustering with no statistical analysis
applied. (B) Multi-group comparison (FDR=0.05) based on treatments. (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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cell line with different materials, including glyphosate, the surfactant
POEA, their mixture and two commercially available POEA-free gly-
phosate-based formulations. As a first step, the DC maturation marker
CD86 was investigated (Fig. 2). While the positive control PPD led to a
significant upregulation of CD86, none of the formulations or POEA did
compared to control. However, glyphosate induced a significant
downregulation of CD86. Furthermore, the skin sensitizing capacity of
the test materials was determined (Fig. 3). Glyphosate was predicted as
a non-sensitizer and the two glyphosate-containing formulations and
POEA were labelled as sensitizers. Corroborating these findings, POEA
and five out of six glyphosate-containing formulations were previously
identified to be potentially skin (photo)sensitizing using in chemico
analyses [10]. In contrast, glyphosate tested alone showed negative
results in the same study. Moreover, in the here presented study, gly-
phosate together with POEA resulted in a similar GARD™ DV when
compared to POEA alone, indicating that glyphosate likely does not
increase the sensitizing capacity when co-administrated with POEA.
Even though the two formulations do not contain POEA as surfactant
(but alkyl poly glucoside and ether amine ethoxylate in Roundup® Flex
and Jablo, respectively), we observed a higher GARD™ DV for these
formulations when compared to POEA. This illustrates that “real-life”
formulations can show a hazard profile different from that observed for
pure ingredients such as the surfactants and the active ingredient gly-
phosate. However, as the surfactants used in Roundup® Flex and Jablo
were not tested in this study, we cannot make any conclusions about
their skin sensitizing characteristics.
Furthermore, the transcriptomic data were complemented with a
proteomic analysis to better understand the toxicological mechanisms
involved in the skin sensitization process triggered by POEA and the
formulations tested. The assembled protein groups, deduced from the
peptides obtained from the MS analysis, revealed several patterns in
response to the formulations. At first, the analysis of all protein groups
(n=6029) resulted in a clear separation between sensitizers and non-
sensitizers (Fig. 4A). Further, by investigating the similarities between
the expressed protein groups using a multigroup ANOVA (FDR=0.05)
(Fig. 4B), four clusters were seen. Interestingly, Jablo clustered with
POEA, indicating similarities in their protein regulation, even though
Jablo is a POEA-free formulation.
To assess the cellular processes and enriched pathways involved in
the response towards these agrochemical materials, we further ana-
lyzed the differentially regulated (FDR=0.05) protein groups, identi-
fied by comparing each glyphosate formulation and POEA to the con-
trol group (Fig. 5). Investigating the commonly regulated proteins more
in detail, we observed three proteins, namely DHCR7, DHCR24,
Fig. 5. Differentially regulated protein groups. Volcano plots with differentially regulated (FDR≤ 0.05, fold change> 1.3) protein groups marked in blue in
exposures with Roundup® Flex (A), Jablo (B) and POEA (C). Horizontal dashed line represents FDR=0.05 while the two vertical dashed lines represent fold
change=1.3. Venn diagram (D) displaying overlapping differentially regulated protein groups for the two herbicidal formulations Jablo and Roundup® Flex, and the
surfactant POEA. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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CYP51A1, which are also represented by transcripts of the 200 bio-
markers in the GARD™skin prediction signature. These enzymes are
involved in cholesterol biosynthesis, where more than 20 enzymes are
required in total; DHCR7 converts dehydrodesmosterol to desmosterol
while DHCR24, in turn, reduces it to cholesterol as final steps [60].
Interestingly, DHCR24 is further included in the 52 transcripts identi-
fied by Zeller et al. to predict skin sensitizer potency using GARD™
technology [33].
Fig. 6. Enriched pathways predicted to be activated by exposure with the herbicidal formulations and surfactant POEA. Pathway enrichment hits predicted in
exposures with (A) Roundup® Flex (365 protein groups), (B) Jablo (140 protein groups) and (C) POEA (124 protein groups) using KPA. Significance level for input
variables into KPA was FDR=0.05 and a fold change cut-off of 1.3. Only the pathways with a –log(p-value) > 3.88 are shown, Roundup® Flex (n=13), Jablo
(n=25) and POEA (n=5).
T. Lindberg, et al. Journal of Proteomics 217 (2020) 103647
8
Naturally, lipids of the membrane bilayer are crucial for the dy-
namics of virtually all cell-environment interactions due to involvement
in processes such as internalization, transport and signalling. Indeed,
several reports have been published indicating that cholesterol, oxy-
sterols and proteins regulating sterol traffic can influence differentia-
tion, maturation and migration of DCs [reviewed in [61]] in the context
of allergy, asthma, and autoimmune diseases. However, studies in-
vestigating the role of cholesterol and associated processes specifically
for DC activation in skin sensitization are to our knowledge not avail-
able. Interestingly, a link between innate immune responses and cho-
lesterol homeostasis has previously been established for macrophage
function [62]. It has further been reported that Toll-like receptor (TLR)
4 activation in macrophages causes lanosterol, the first sterol inter-
mediate in the cholesterol biosynthetic pathway, to accumulate by
down-regulation of CYP51A1. In turn, lanosterol accumulation in-
creases both membrane fluidity and ROS production, which increases
phagocytosis and the ability to kill bacteria [63]. Another study con-
nects sterol regulatory element binding protein-1a (SREBP-1a) to acti-
vation of lipogenesis genes in macrophages and of a core inflammasome
component, NOD-like receptor (NLR) family pyrin domain containing 1
(Nlrp1a), thus linking lipid metabolism to the innate immune response
[62]. The authors further hypothesize that SREBP-1a “evolved to reg-
ulate cellular reactions to external challenges that range from nutrient
limitation and hypoxia to toxins and pathogens”. Notably, cells under
stress can release damage-associated molecular patterns, which are
recognized by pattern recognition receptors (PRRs) including families
of TLRs and NLRs [64]. More recently, PRRs, especially TLRs, have
been shown to regulate DNA repair by modulating the expression of
several enzymes involved in this response, among them TYMS [65].
Each protein group was further associated with gene(s) and used as
input in the KPA analysis. This revealed several pathways (Fig. 6),
which seem biologically relevant in the context of skin sensitization, for
example “IL-4-induced regulators of cell growth, survival, differentia-
tion and metabolism” and “ROS-induced cellular signalling”, both
linked to immune responses [66,67]. Furthermore, two of the predicted
pathways found in response to chemical exposures of POEA, Roundup®
Flex and Jablo, namely, “Sirtuin6 regulation and functions” and
“mTORC1 downstream signaling”, have been linked to inflammation
[68] and metabolic responses in immune cell activation [69], respec-
tively. mTOR, a core component of the mTORC1 protein complex, is a
serine/threonine kinase considered a master regulator of cellular me-
tabolism. mTORC1 controls the balance between anabolism and cata-
bolism in response to environmental conditions and regulates the pro-
duction of proteins, lipids and nucleotides while e.g. suppressing
catabolic pathways such as autophagy [70]. Sirtuins (SIRTs1-7) are
histone deacetylase enzymes and in general involved in the regulation
of cell stress responses and metabolism [71]. Among them, SIRT2,
SIRT6, and SIRT7 are described as key modulators of oxidative stress
genes and associated molecular mechanisms [72]. Sirtuins are also able
to induce autophagy, e.g. SIRT6-mediated induction of autophagy has
been described to be crucial for several processes in normal cells such as
the monocyte differentiation [73]. Furthermore, literature strongly
supports a role of autophagy for DC function on several levels and it
appears both up- and downstream of redox signalling [74] and in in-
flammatory pathways of allergy and asthma [75].
To this end, when combining our results on regulated proteins and
predicted pathways, an association to autophagy processes seems rather
clear. Autophagy is a fundamental process for degrading and recycling
cellular components and most data available focuses on macro-
autophagy. This process leads to bulk lysosomal degradation of the
cytosol via specialized double-membrane organelles (autophagosomes)
[74]. Additionally, mTOR plays a major role in regulating autophagy
and is suggested as a pharmacological target for autophagy regulation
[76]. p62/SQSTM1, which was found to be one of the proteins regu-
lated with the highest fold changes in this study, binds ubiquitylated
protein aggregates and delivers them to the autophagosomes [77].
Generally, upon autophagy activation, p62/SQSTM1 levels decrease,
indicating that the cell exposure to POEA and the multi-component
formulations could interfere with autophagy flux as they induce p62/
SQSTM1 up-regulation as found in our DC cell model. To date, very few
reports suggest a role of autophagy in skin sensitization. The sensitizer
1-fluoro-2,4-dinitrobenzene (DNFB) was reported to modulate ma-
turation of THP-1, a myeloid cell line, and to stabilize the transcription
factor Nrf2, known to trigger expression of antioxidant proteins, by
induction of two autophagy-related genes [78]. Lee et al. reported that
treatment with the sensitizer chromium-IV induced apoptosis, autop-
hagy and ROS in keratinocyte HaCaT cells [79]. Furthermore, one study
not related to skin sensitization associated glyphosate-induced cell
death with autophagy pathways in the rat cell line PC12 [80].
5. Conclusions
In summary, we here present an integrative analysis involving ad-
vanced technologies to elucidate the molecular mechanisms underlying
DC activation in the skin sensitization process triggered by agrochem-
ical materials. Given the frequent use of products consisting of complex
mixtures, such as glyphosate formulations, it is crucial that tox-
icological assessments on both co-formulants and the “real-life” for-
mulations are performed to evaluate their impact on human health. In
this regard, the integration of GARD™skin and proteomic data can
elucidate the xenobiotic-induced skin sensitization capacity of the
agrochemical materials and contribute to the understanding of im-
munotoxicity-associated molecular mechanisms involved. In this con-
text, the data presented here are in line with autophagy playing a role
in the DC response triggered by glyphosate-based formulations and
POEA, and likely in skin sensitization more in general. Hence, our data
provide a mechanism-based hazard evaluation of xenobiotics that can
be used to support human health risk assessment.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jprot.2020.103647.
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